-
Mashup Score: 0Breakthrough Devices Program - 4 year(s) ago
Learn about the Breakthrough Devices Program benefits, criteria and how to request a designation.
Categories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2
June 21, 2021—Abbott announced via an email communication that the company has received FDA Breakthrough Device designation for its investigatio
Source: Cardiac Interventions TodayCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1Navitor Shuts Out Leaky TAVR, but Pacemaker Rates a Concern? - 4 year(s) ago
30-day data for a new version of the Portico valve
Source: www.medpagetoday.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1
Valve replacement, particularly TAVI, showed promise as an early intervention, but a randomized trial is ongoing.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 3
Abdelkader Almanfi, MD, and James O’Rourke, MD, launched a TAVR program at Lourdes Hospital last year. Today, they have helped more than 50 patients.
Source: Mercy Health BlogCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Abbott’s new self-expanding TAVR system gains CE mark approval - 4 year(s) ago
Abbott announced May 17 that the company has gained CE mark approval for its Navitor transcatheter aortic valve replacement (TAVR) system. As a result, TAVR with the self-expanding Navitor system is now available to high-risk patients with severe aortic stenosis in Europe. Navitor was designed using Abbott’s FlexNav delivery system and the…
Source: Cardiovascular BusinessCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0A milestone for Medtronic: Low-risk TAVR patients treated with Evolut ‘doing exceptionally well’ after 2 years - 4 year(s) ago
After two years, low-risk patients treated with Medtronic’s Evolut transcatheter aortic valve repair (TAVR) system continue to experience outcomes similar to those who underwent surgery, according to new data presented virtually at EuroPCR 2021. In fact, researchers behind the Evolut Low Risk Trial shared, the two-year rates of all-cause…
Source: Cardiovascular BusinessCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Significant MR after TAVR linked to higher mortality rates—but staged interventions may help - 4 year(s) ago
The analysis included data from nearly 2,000 patients who received care at one of 16 TAVR facilities from 2007 to 2019. Patients with previous mitral valve surgery were excluded. Overall, the team found that MR regressed in 44.1% of patients after TAVR, but persisted in the remaining 55.9%. Four-year mortality was higher for patients with…
Source: Cardiovascular BusinessCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
This year, spring yard work has been possible for Linda Stetson thanks to a mitral heart valve replacement via a MitraClip procedure.
Source: Mercy Health BlogCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1WATCHMAN FLX LAAC Device Product Animation - 4 year(s) agoSource: YouTubeCategories: Cardiologists, Latest HeadlinesTweet
https://t.co/anv4aeDc8p